{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:25:26Z","timestamp":1789503926340,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33516-3","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T01:07:48Z","timestamp":1766452068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical presentation and outcomes of children hospitalized with sickle cell anemia at Gulu regional referral hospital, Uganda: a retrospective cross-sectional study"],"prefix":"10.1038","volume":"16","author":[{"given":"Keneth","family":"Okello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morrish Obol","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred Sual","family":"Chemutai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezereth","family":"Nakasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Catherine","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Kayina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"33516_CR1","unstructured":"World Health Organization. Overview of Sickle Cell Disease (2025). https:\/\/www.afro.who.int\/health-topics\/sickle-cell-disease"},{"key":"33516_CR2","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","volume":"41","author":"SD Grosse","year":"2011","unstructured":"Grosse, S. D. et al. Sickle cell disease in Africa. Am. J. Prev. Med. 41, S398\u2013405. https:\/\/doi.org\/10.1016\/j.amepre.2011.09.013 (2011).","journal-title":"Am. J. Prev. Med."},{"key":"33516_CR3","doi-asserted-by":"publisher","unstructured":"Obeagu, E. I., Opoku, D. & Obeagu, G. U. Sickle cell anaemia. Curr. Burd. Afr. 12\u201315. https:\/\/doi.org\/10.58538\/IJIAR\/2011 (2023).","DOI":"10.58538\/IJIAR\/2011"},{"key":"33516_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijns5020020","volume":"5","author":"B Inusa","year":"2019","unstructured":"Inusa, B. et al. Sickle cell Disease\u2014Genetics, Pathophysiology, clinical presentation and treatment. Int. J. Neonatal Screen. 5, 20. https:\/\/doi.org\/10.3390\/ijns5020020 (2019).","journal-title":"Int. J. Neonatal Screen."},{"key":"33516_CR5","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/S2214-109X(15)00288-0","volume":"4","author":"G Ndeezi","year":"2016","unstructured":"Ndeezi, G. et al. Burden of sickle cell trait and disease in the Uganda sickle surveillance study (US3): a cross-sectional study. Lancet Glob Heal. 4, e195\u2013200. https:\/\/doi.org\/10.1016\/S2214-109X(15)00288-0 (2016).","journal-title":"Lancet Glob Heal"},{"key":"33516_CR6","first-page":"81","volume":"31","author":"JP Ambe","year":"2020","unstructured":"Ambe, J. P., Mava, Y., Chama, R., Farouq, G. & Machoko, Y. Clinical features of sickle cell anaemia in Northern Nigerian children. West. Afr. J. Med. 31, 81\u201385 (2020).","journal-title":"West. Afr. J. Med."},{"key":"33516_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12878-018-0122-3","volume":"18","author":"HR Sawe","year":"2018","unstructured":"Sawe, H. R. et al. The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania. BMC Hematol. 18, 25. https:\/\/doi.org\/10.1186\/s12878-018-0122-3 (2018).","journal-title":"BMC Hematol."},{"key":"33516_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjh.12786","volume":"165","author":"P Connes","year":"2014","unstructured":"Connes, P. et al. Haemolysis and abnormal haemorheology in sickle cell anaemia. Br. J. Haematol. 165, 564\u2013572. https:\/\/doi.org\/10.1111\/bjh.12786 (2014).","journal-title":"Br. J. Haematol."},{"key":"33516_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd, P., Gladwin, M. T. & Novelli, E. M. Pathophysiology of sickle cell disease. Annu. Rev. Pathol. Mech. Dis. 14, 263\u2013292. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012838 (2019).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"33516_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12913-024-11125-6","volume":"24","author":"P Namaganda","year":"2024","unstructured":"Namaganda, P., Nantume, P., Mubiru, K. R., Twimukye, A. & Wiltshire, C. S. Understanding patient-related barriers to hydroxyurea use among adolescent and adult patients with sickle cell disease in Mulago and Kiruddu hospitals, Uganda, a qualitative study. BMC Health Serv. Res. 24, 666. https:\/\/doi.org\/10.1186\/s12913-024-11125-6 (2024).","journal-title":"BMC Health Serv. Res."},{"key":"33516_CR11","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J. & Williams, T. N. Global burden of sickle cell anaemia in children under Five, 2010\u20132050: modelling based on Demographics, excess Mortality, and interventions. PLoS Med. 10, e1001484. https:\/\/doi.org\/10.1371\/journal.pmed.1001484 (2013).","journal-title":"PLoS Med."},{"key":"33516_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/10245332.2015.1101976","volume":"21","author":"H Saidi","year":"2016","unstructured":"Saidi, H. et al. Complications of sickle cell anaemia in children in Northwestern Tanzania. Hematology 21, 248\u2013256. https:\/\/doi.org\/10.1080\/10245332.2015.1101976 (2016).","journal-title":"Hematology"},{"key":"33516_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ped.2017.0814","volume":"30","author":"S Jain","year":"2017","unstructured":"Jain, S., Bakshi, N. & Krishnamurti, L. Acute chest syndrome in children with sickle cell disease. Pediatr. Allergy Immunol. Pulmonol. 30, 191\u2013201. https:\/\/doi.org\/10.1089\/ped.2017.0814 (2017).","journal-title":"Pediatr. Allergy Immunol. Pulmonol."},{"key":"33516_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.15537\/smj.2019.4.24049","volume":"40","author":"AAA Elmoneim","year":"2019","unstructured":"Elmoneim, A. A. A. et al. Causes of hospitalization in sickle cell diseased children in Western region of Saudi Arabia. A single center study. Saudi Med. J. 40, 401\u2013404. https:\/\/doi.org\/10.15537\/smj.2019.4.24049 (2019).","journal-title":"Saudi Med. J."},{"key":"33516_CR15","doi-asserted-by":"publisher","first-page":"e104303","DOI":"10.1136\/bmjopen-2025-104303","volume":"15","author":"W Kibone","year":"2025","unstructured":"Kibone, W. et al. Indications for hospitalisation and predictors of 30-day re-admission of patients with sickle cell disease in uganda: a retrospective study. BMJ Open. 15, e104303. https:\/\/doi.org\/10.1136\/bmjopen-2025-104303 (2025).","journal-title":"BMJ Open."},{"key":"33516_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/jmwa.jmwa","volume":"6","author":"DY Buowari","year":"2021","unstructured":"Buowari, D. Y. et al. Physicians \u2019 trust in health systems Nigeria. J. Med. Womens Assoc. Niger. 6, 129\u2013135. https:\/\/doi.org\/10.4103\/jmwa.jmwa (2021).","journal-title":"J. Med. Womens Assoc. Niger"},{"key":"33516_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.33425\/2689-1085.1049","volume":"4","author":"OS Magzoub","year":"2022","unstructured":"Magzoub, O. S., Magid, I. E. H., Zayed, M. A. & Munir, R. A. First and common clinical presentation of sickle cell disease in children. J. Pediatr. Neonatol. 4, 4\u20138. https:\/\/doi.org\/10.33425\/2689-1085.1049 (2022).","journal-title":"J. Pediatr. Neonatol"},{"key":"33516_CR18","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1182\/blood-2022-159339","volume":"140","author":"K Kaur","year":"2022","unstructured":"Kaur, K., Faisal, A., Kennedy, K., Knupp, C. L. & Liles, D. Causes of mortality in sickle cell disease patients: A longitudinal review of deceased sickle cell patients. Blood 140, 5440\u20135441. https:\/\/doi.org\/10.1182\/blood-2022-159339 (2022).","journal-title":"Blood"},{"key":"33516_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/pch\/pxab096","volume":"27","author":"CE Beck","year":"2022","unstructured":"Beck, C. E., Trottier, E. D., Kirby-Allen, M. & Pastore, Y. Acute complications in children with sickle cell disease: prevention and management. Paediatr. Child. Health. 27, 50\u201355. https:\/\/doi.org\/10.1093\/pch\/pxab096 (2022).","journal-title":"Paediatr. Child. Health"},{"key":"33516_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/atm.atm_575_21","volume":"17","author":"AA Yousef","year":"2022","unstructured":"Yousef, A. A. et al. Acute chest syndrome in pediatric sickle cell disease. Ann. Thorac. Med. 17, 199\u2013206. https:\/\/doi.org\/10.4103\/atm.atm_575_21 (2022).","journal-title":"Ann. Thorac. Med."},{"key":"33516_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajem.2022.06.018","volume":"58","author":"JL Koehl","year":"2022","unstructured":"Koehl, J. L., Koyfman, A., Hayes, B. D. & Long, B. High risk and low prevalence diseases: acute chest syndrome in sickle cell disease. Am. J. Emerg. Med. 58, 235\u2013244. https:\/\/doi.org\/10.1016\/j.ajem.2022.06.018 (2022).","journal-title":"Am. J. Emerg. Med."},{"key":"33516_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.hemonc.2019.12.007","volume":"13","author":"MR Abboud","year":"2020","unstructured":"Abboud, M. R. Standard management of sickle cell disease complications \u2606. Hematol. Oncol. Stem Cell. Ther. 13, 85\u201390. https:\/\/doi.org\/10.1016\/j.hemonc.2019.12.007 (2020).","journal-title":"Hematol. Oncol. Stem Cell. Ther."},{"key":"33516_CR23","unstructured":"MOH Uganda. Uganda\u2019s National Sickle Cell Disease Guidelines. 2025. (2020)."},{"key":"33516_CR24","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","volume":"14","author":"PT McGann","year":"2015","unstructured":"McGann, P. T. & Ware, R. E. Hydroxyurea therapy for sickle cell anemia. Expert Opin. Drug Saf. 14, 1749\u20131758. https:\/\/doi.org\/10.1517\/14740338.2015.1088827 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"33516_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/03630269.2012.709897","volume":"36","author":"DK Patel","year":"2012","unstructured":"Patel, D. K. et al. Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from Eastern India. Hemoglobin 36, 409\u2013420. https:\/\/doi.org\/10.3109\/03630269.2012.709897 (2012).","journal-title":"Hemoglobin"},{"key":"33516_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/MOH.0000000000000582","volume":"27","author":"A Power-Hays","year":"2020","unstructured":"Power-Hays, A. & Ware, R. E. Effective use of hydroxyurea for sickle cell anemia in low-resource countries. Curr. Opin. Hematol. 27, 172\u2013180. https:\/\/doi.org\/10.1097\/MOH.0000000000000582 (2020).","journal-title":"Curr. Opin. Hematol."},{"key":"33516_CR27","unstructured":"WHO. Strategic Guidance Framework Module 1 WHO SICKLE Package of Interventions for Sickle Cell Disease Management Strategic Guidance Framework 2024."},{"key":"33516_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/136485907X154638","volume":"101","author":"J Makani","year":"2007","unstructured":"Makani, J., Williams, T. N. & Marsh, K. Sickle cell disease in africa: burden and research priorities. Ann. Trop. Med. Parasitol. 101, 3\u201314. https:\/\/doi.org\/10.1179\/136485907X154638 (2007).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"33516_CR29","unstructured":"National Guidelines for Research Involving Humans as Research Participants. National Guidelines for Research Uganda National Council for Science and Technology (2014)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33516-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:27:25Z","timestamp":1769509645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33516-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33516"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33516-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Gulu University Research Ethics Committee (GUREC-2024-796). A waiver of informed consent was granted due to the retrospective nature of the study and minimal risk to participants, as it involved the analysis of de-identified medical records. All methods were performed in accordance with the Declaration of Helsinki and the Uganda National Council for Science and Technology (UNCST) guidelines (Sect. 5.8, 2014) for research involving human participants\n                      29\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"3586"}}